[go: up one dir, main page]

SE0301796D0 - New use II - Google Patents

New use II

Info

Publication number
SE0301796D0
SE0301796D0 SE0301796A SE0301796A SE0301796D0 SE 0301796 D0 SE0301796 D0 SE 0301796D0 SE 0301796 A SE0301796 A SE 0301796A SE 0301796 A SE0301796 A SE 0301796A SE 0301796 D0 SE0301796 D0 SE 0301796D0
Authority
SE
Sweden
Prior art keywords
new use
functional
thiocromans
enantiomers
salts
Prior art date
Application number
SE0301796A
Other languages
English (en)
Inventor
Seth-Olov Thorberg
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Priority to SE0301796A priority Critical patent/SE0301796D0/sv
Publication of SE0301796D0 publication Critical patent/SE0301796D0/sv
Priority to TW093116446A priority patent/TW200510363A/zh
Priority to ARP040102083A priority patent/AR044716A1/es
Priority to PCT/SE2004/000963 priority patent/WO2004110430A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/382—Heterocyclic compounds having sulfur as a ring hetero atom having six-membered rings, e.g. thioxanthenes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SE0301796A 2003-06-19 2003-06-19 New use II SE0301796D0 (sv)

Priority Applications (4)

Application Number Priority Date Filing Date Title
SE0301796A SE0301796D0 (sv) 2003-06-19 2003-06-19 New use II
TW093116446A TW200510363A (en) 2003-06-19 2004-06-08 Use of substituted chromans or thiocromans for the treatment of FGD
ARP040102083A AR044716A1 (es) 2003-06-19 2004-06-16 Uso de cromanos o tiocromanos substituidos para el tratamiento de trastornos gastrointestinales funcionales
PCT/SE2004/000963 WO2004110430A1 (en) 2003-06-19 2004-06-16 Use of substituted chromans or thiocromans for the treatment of fgd

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0301796A SE0301796D0 (sv) 2003-06-19 2003-06-19 New use II

Publications (1)

Publication Number Publication Date
SE0301796D0 true SE0301796D0 (sv) 2003-06-19

Family

ID=27607361

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0301796A SE0301796D0 (sv) 2003-06-19 2003-06-19 New use II

Country Status (4)

Country Link
AR (1) AR044716A1 (sv)
SE (1) SE0301796D0 (sv)
TW (1) TW200510363A (sv)
WO (1) WO2004110430A1 (sv)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8904361D0 (sv) * 1989-12-22 1989-12-22 Astra Ab New chroman and thiochroman derivatives
US5420151A (en) * 1989-12-22 1995-05-30 Aktiebolaget Astra Chroman derivatives
IL100858A (en) * 1991-02-08 1996-03-31 Lilly Co Eli Ring-substituted 2-amino-1,2 3,4- tetrahydronaphthalenes and 3-aminochromanes pharmaceutical compositions containing them and methods for their preparation
US5434174A (en) * 1992-07-17 1995-07-18 Eli Lilly And Company Isoxazole derivatives for the treatment of irritable bowel syndrome
SE510305C2 (sv) * 1997-05-30 1999-05-10 Astra Ab Nytt salt

Also Published As

Publication number Publication date
TW200510363A (en) 2005-03-16
WO2004110430A1 (en) 2004-12-23
AR044716A1 (es) 2005-09-21

Similar Documents

Publication Publication Date Title
SE0203713D0 (sv) Novel compounds
UA87153C2 (ru) Энантиомерно чистые аминогетероарильные соединения как ингибиторы протеинкиназы
SE0303180D0 (sv) Novel compounds
SE0302232D0 (sv) Novel Compounds
CY1109104T1 (el) 1,2,3,4 τετρα-υποκατεστημενη ινδολη για την αντιμετωπιση ασθενειων του αναπνευστικου
CY1112238T1 (el) Αναστολεις μιτωτικης κινεσινης και μεθοδοι χρησης αυτων
DE602006010243D1 (de) 4-(Phenylamino)-6-oxo-1,6-dihydropyridazine-3-carboxamid Derivate als MEK Inhibitoren zur Behandlung von hyperproliferativen Erkrankungen
NO20060230L (no) Nye aminobenzofenonforbindelser
CY1108808T1 (el) Ενωσεις μοτιλιδης
EA200700982A1 (ru) Производные хинолина и изохинолина, замещённые в 5-ом положении, способ их получения и их применение в качестве противовоспалительных средств
NO20043952L (no) Benzofuran- og benzotiofenderivater som er nyttige ved behandling av hyperproliferative forstyrrelser
NO20073839L (no) Kinolinderivat, fremgangsmate for fremstilling og anvendelse av dette, og legemiddel inneholdende dette
ATE486597T1 (de) 3,4-substituierte pyrrolidin-derivate zur behandlung von hypertonie
SE0401465D0 (sv) New substituted piperdines as modulators of dopamine neurotransmission
NO20055741D0 (no) Nye kjemiske forbindelser
NO20054361D0 (no) Benzensylfonamidderivater, fremgangsmate for fremstilling og anvendelse derav for behandlig av smerte
EA201290504A1 (ru) Новые производные (конденсированный гетероцикл-пиперидин)-(пиперазинил)-1-алканона или (конденсированный гетероцикл-пирролидин)-(пиперазинил)-1-алканона и их применение в качестве ингибиторов р75
EA200700400A1 (ru) Производные n-(1h-индолил)-1н-индол-2-карбоксамидов, их получение и их применение в терапии
NO20055563L (no) Midler for behandlingen av lavere abdominale lidelser
IS7021A (is) Nýjar heteróarýlafleiður, framleiðsla þeirra og notkun
EA200400438A1 (ru) Применение ирбесартана для изготовления лекарств, которые пригодны для предупреждения или лечения лёгочной гипертонии
DE602004019541D1 (de) Cycloalkyläbü kondensierte indole
SE0301796D0 (sv) New use II
EA200600115A1 (ru) Производные 2-аминобензойной кислоты
DE602006020585D1 (de) Neue cysteinproteasehemmer und ihre therapeutische anwendung